Thomas E. Morrison

7.6k total citations · 1 hit paper
116 papers, 5.5k citations indexed

About

Thomas E. Morrison is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Thomas E. Morrison has authored 116 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Infectious Diseases, 71 papers in Public Health, Environmental and Occupational Health and 28 papers in Immunology. Recurrent topics in Thomas E. Morrison's work include Mosquito-borne diseases and control (68 papers), Viral Infections and Vectors (53 papers) and Viral Infections and Outbreaks Research (29 papers). Thomas E. Morrison is often cited by papers focused on Mosquito-borne diseases and control (68 papers), Viral Infections and Vectors (53 papers) and Viral Infections and Outbreaks Research (29 papers). Thomas E. Morrison collaborates with scholars based in United States, France and Australia. Thomas E. Morrison's co-authors include Mark T. Heise, Michael Diamond, Alan C. Whitmore, Stephanie A. Montgomery, Kristina S. Burrack, Ralph S. Baric, Shannon C. Kenney, Lauren Oko, Timothy P. Sheahan and Mary K. McCarthy and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Thomas E. Morrison

112 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

2018 479 citations Thomas E. Morrison, Mark T. Heise et al. profile →

Peers

Countries citing papers authored by Thomas E. Morrison

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Morrison more than expected).

Fields of papers citing papers by Thomas E. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Morrison. The network helps show where Thomas E. Morrison may publish in the future.

Co-authorship network of co-authors of Thomas E. Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Morrison. A scholar is included among the top collaborators of Thomas E. Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Morrison. Thomas E. Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep mutationally scanned CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies 2025 ·Journal of Virology ·Megan M. Stumpf, Tonya M. Brunetti, Bennett Davenport, Mary K. McCarthy, Thomas E. Morrison	2
2	Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO 2024 ·JCI Insight ·(unknown), Ryan M. Sheridan, Glennys V. Reynoso, Bennett Davenport, Mary K. McCarthy, (unknown), Jay R. Hesselberth, Heather D. Hickman, Beth A. Jirón Tamburini, Thomas E. Morrison	1
3	Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine Candidate 2024 ·Vaccines ·(unknown), Bennett Davenport, Thomas E. Morrison, Carlos E. Catalano	1
4	Phagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner 2024 ·PNAS Nexus ·Stephanie E. Ander, (unknown), Bennett Davenport, (unknown), Angela M. Bosco‐Lauth, (unknown), Chengqun Sun, (unknown), William B. Klimstra, Gregory D. Ebel, Thomas E. Morrison	4
5	Immunization-induced antigen archiving enhances local memory CD8+ T cell responses following an unrelated viral infection 2024 ·npj Vaccines ·(unknown), (unknown), (unknown), Erin D. Lucas, Ira Fleming, (unknown), (unknown), Jenna J. Guthmiller, Jay R. Hesselberth, Thomas E. Morrison, Beth A. Jirón Tamburini	2
6	Investigation of the Consumer Perspective on Leisure in Mental Health Inpatient Units 2023 ·OTJR Occupational Therapy Journal of Research ·(unknown), Kieran Broome, Marion Gray, (unknown), Thomas E. Morrison, Manaan Kar Ray	1
7	Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease 2022 ·npj Vaccines ·Bennett Davenport, (unknown), Stuart Weston, Robert M. Johnson, (unknown), Holly Hammond, Carly Dillen, Matthew B. Frieman, Carlos E. Catalano, Thomas E. Morrison	16
8	MARCO ⁺ lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination 2021 ·The EMBO Journal ·(unknown), Ryan M. Sheridan, (unknown), Bennett Davenport, (unknown), Erin D. Lucas, Mary K. McCarthy, Glennys V. Reynoso, Nicholas May, Beth A. Jirón Tamburini, Jay R. Hesselberth, Heather D. Hickman, Thomas E. Morrison	21
9	Presence and short‐term persistence of SARS‐CoV ‐2 neutralizing antibodies in COVID ‐19 convalescent plasma donors 2021 ·Transfusion ·Kyle Annen, Thomas E. Morrison, (unknown), Mary K. McCarthy, (unknown), Patricia Merkel, (unknown), (unknown), Vijaya Knight	9
10	Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease 2020 ·PLoS Pathogens ·(unknown), Julie M. Fox, Nurgun Kose, Arthur S. Kim, (unknown), Robin Bombardi, Robert H. Carnahan, James C. Slaughter, Thomas E. Morrison, Michael Diamond, James E. Crowe	20
11	MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2 2020 ·PLoS Pathogens ·Mary K. McCarthy, Glennys V. Reynoso, Emma S. Winkler, Matthias Mack, Michael Diamond, Heather D. Hickman, Thomas E. Morrison	27
12	dsRNA-Seq: Identification of Viral Infection by Purifying and Sequencing dsRNA 2019 ·Viruses ·Carolyn J. Decker, (unknown), Laura L. Hoon‐Hanks, James H. Morrison, K. Haist, (unknown), Eric M. Poeschla, Thomas E. Morrison, Mark D. Stenglein, Sara L. Sawyer, Roy Parker	18
13	Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response 2018 ·The Journal of Immunology ·Erin D. Lucas, (unknown), Matthew A. Burchill, Mary K. McCarthy, Thomas E. Morrison, Tonya M. Colpitts, Beth A. Jirón Tamburini	48
14	Mutations in the E2 Glycoprotein and the 3′ Untranslated Region Enhance Chikungunya Virus Virulence in Mice 2017 ·Journal of Virology ·David W. Hawman, (unknown), Julie M. Fox, Nicholas May, Wes Sanders, Stephanie A. Montgomery, Nathaniel J. Moorman, Michael Diamond, Thomas E. Morrison	32
15	Animal Models of Zika Virus Infection, Pathogenesis, and Immunity 2017 ·Journal of Virology ·Thomas E. Morrison, Michael Diamond	204
16	Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis 2015 ·Journal of Clinical Investigation ·Leticia Monin, Kristin Griffiths, Wing Y. Lam, Radha Gopal, Dongwan Kang, Mushtaq Ahmed, Anuradha Rajamanickam, Alfredo Cruz‐Lagunas, Joaquı́n Zúñiga, Subash Babu, Jay K. Kolls, Makedonka Mitreva, Bruce A. Rosa, Rosalío Ramos‐Payán, Thomas E. Morrison, Peter J. Murray, Javier Rangel‐Moreno, Edward J. Pearce, Shabaana A. Khader	80
17	A Single-Amino-Acid Polymorphism in Chikungunya Virus E2 Glycoprotein Influences Glycosaminoglycan Utilization 2013 ·Journal of Virology ·Laurie A. Silva, Solomiia Khomandiak, Alison W. Ashbrook, Romy Weller, Mark T. Heise, Thomas E. Morrison, Terence S. Dermody	108
18	Complement and viral pathogenesis 2011 ·Virology ·(unknown), Thomas E. Morrison	200
19	Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein 2010 ·Virology ·Catherine C. Cruz, Mehul S. Suthar, Stephanie A. Montgomery, Reed S. Shabman, Jason D. Simmons, Robert E. Johnston, Thomas E. Morrison, Mark T. Heise	38
20	NLRX1 is a regulator of mitochondrial antiviral immunity 2008 ·Nature ·Chris B. Moore, Dan T. Bergstralh, Joseph A. Duncan, Yu L. Lei, Thomas E. Morrison, Albert Zimmermann, Mary Ann Accavitti-Loper, Victoria J. Madden, Lijun Sun, Zhengmao Ye, John D. Lich, Mark T. Heise, Zhijian J. Chen, Jenny P.‐Y. Ting	466

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact